e-Therapeutics Share Price (ETX)
| Bid price | 28.50 | Open price | 29.00 |
|---|---|---|---|
| Ask price | 29.50 | Prev close | 29.00 |
| High price | 29.25 | Spread | 3.39% |
| Low price | 29.25 | Volume | 11,025 |
Register now for FREE live e-Therapeutics share prices, e-Therapeutics stock quotes, charts, trades and FREE e-Therapeutics company fundamentals, market news and much much more. Why not upgrade to a premium service and get e-Therapeutics Level 2 Data, indepth research tools and investor commentary for e-Therapeutics (ETX) and other London Stock Exchange equities.
e-Therapeutics Share Price Chart
Register now for FREE e-Therapeutics share price charts
e-Therapeutics Share Price Information
| Name | e-Therapeutics | Epic | ETX |
|---|---|---|---|
| Activites | Develops and discovers systems biology drugs | Reuters | ETX.L |
| ISIN | GB00B2823H99 | Google Finance | LON:ETX |
| Share Price (p) | 29.00 | Prev. Share Price (p) | 29.00 |
|---|---|---|---|
| Shares in Issue (m) | 138 | Market Cap (£m) | 40 |
| PE Ratio (x) | -7.26 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -3.50 | PEG |
Register now for FREE e-Therapeutics company fundamentals
e-Therapeutics Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 27/10/2011 | BUY | Prof Oliver James | CH | 25,000 |
| 17/08/2011 | BUY | Steve Self | ED | 56,600 |
| 28/07/2011 | BUY | Dr Daniel Elger | FD | 15,000 |
| 24/05/2011 | BUY | Steve Self | ED | 13,698 |
| 23/05/2011 | BUY | Steve Self | ED | 20,189 |
e-Therapeutics Company News
e-Therapeutics to present at NY conference
e-Therapeutics chief financial officer Dr Daniel Elger will present an overview of the company's strategy, platform and clinical development programmes at the 14th annual BIO CEO & Investor Conference in New York on 13 February at 2.00 p.m. EST At 2:06pm: (LON:ETX) share price was +0.5p at...
e-Therapeutics to Present at The 14th Annual BI...
e-Therapeutics to Present at The 14th Annual BIO CEO & Investor Conference e-Therapeutics plc e-Therapeutics to present at the 14 th Annual BIO CEO & Investor Conference Oxford...
Holding(s) in Company
/* */ RNS Number : 9286W e-Therapeutics plc 07 February 2012 Holdings in Company: e-Therapeutics plc 7 February 2012 e-Therapeutics plc (AIM: ETX) was notified on 6 February that, as of 3 February 2012, RAB Special Situations...
More e-Therapeutics Company News >>
Register now for FREE e-Therapeutics company news
e-Therapeutics Share Price Discussions
e-Therapeutics plc (ETX)
('e-Therapeutics' or 'the Company') First Day of Dealings on AIM A placing of 1,985,075 Ordinary Shares at 67 pence each has raised £1.33 million (gross) for the Company. The total issued share capital of the Company is 55,710,103 and the...
Register now for FREE e-Therapeutics share price discussions